Render Target: SSR
Render Timestamp: 2025-03-06T19:15:38.707Z
Commit: 9fc0f116116d9da247dc8ddd4e5fe811153412e1
XML generation date: 2024-09-30 01:59:28.093
Product last modified at: 2025-01-01T09:05:24.546Z
Cell Signaling Technology Logo
1% for the planet logo
PDP - Template Name: Monoclonal Antibody
PDP - Template ID: *******c5e4b77
R Recombinant
Recombinant: Superior lot-to-lot consistency, continuous supply, and animal-free manufacturing.

LZTFL1 (E9R7T) Rabbit mAb #26099

Filter:
  • WB
  • IP
  • IHC

    Supporting Data

    REACTIVITY H M R
    SENSITIVITY Endogenous
    MW (kDa) 38
    Source/Isotype Rabbit IgG
    Application Key:
    • WB-Western Blotting 
    • IP-Immunoprecipitation 
    • IHC-Immunohistochemistry 
    Species Cross-Reactivity Key:
    • H-Human 
    • M-Mouse 
    • R-Rat 

    Product Information

    Product Usage Information

    Application Dilution
    Western Blotting 1:1000
    Immunoprecipitation 1:50
    Immunohistochemistry (Paraffin) 1:200 - 1:400

    Storage

    Supplied in 10 mM sodium HEPES (pH 7.5), 150 mM NaCl, 100 µg/mL BSA, 50% glycerol, and less than 0.02% sodium azide. Store at –20°C. Do not aliquot the antibody.

    Protocol

    Specificity / Sensitivity

    LZTFL1 (E9R7T) Rabbit mAb recognizes endogenous levels of total LZTFL1 protein.

    Species Reactivity:

    Human, Mouse, Rat

    Source / Purification

    Monoclonal antibody is produced by immunizing animals with recombinant protein specific to the amino terminus of human LZTFL1 protein.

    Background

    LZTFL1 (leucine zipper transcription factor-like 1) is highly expressed in the epithelial cells of normal tissues and is a negative regulator of BBSome ciliary trafficking and sonic hedgehog (SHH) signaling. The absence of LZTFL1 leads to a phenotype with enhanced developmental abnormalities, and mutations in LZTFL1 have been reported in patients with Bardet-Biedl syndrome (BBS) (1,2). LZTFL1 has been shown to suppress epithelial mesenchymal transition (EMT), and decreased LZTFL1 expression is associated with tumor growth, metastasis, and poor survival outcome in many cancers (3-5). Genome-wide association studies have identified a gain of function allele in an enhancer region that leads to increased expression of LZTFL1, which is functionally associated with more severe outcomes from SARS-CoV-2 infection (6).
    For Research Use Only. Not For Use In Diagnostic Procedures.
    Cell Signaling Technology is a trademark of Cell Signaling Technology, Inc.
    All other trademarks are the property of their respective owners. Visit our Trademark Information page.